Physician profile
Catherine E Burley
NPI 1124064316
$1,010.66
in general payments reported to CMS, 2019-2025
16 companies · $240 in 2025
The $240 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $188 · 2020: $199 · 2021: $240 · 2022: $14.08 · 2023: $35.78 · 2024: $93.38 · 2025: $240.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $369.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $369.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $201.55 | 2019-2021 | |
| Glaxosmithkline, LLC. | $158.45 | 2020-2025 | Bexsero, Shingrix, Pediarix |
| Lilly USA, LLC | $130.67 | 2021-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $125.00 | 2021 | |
| Allergan, INC. | $125.00 | 2020 | |
| Gilead Sciences, INC. | $35.55 | 2019-2021 | |
| Pfizer INC. | $34.88 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $33.12 | 2019-2024 | Austedo Xr |
| Merck Sharp & Dohme LLC | $32.81 | 2021-2025 | Gardasil 9, Vaxelis, Capvaxive |
| Medline Industries LP | $31.33 | 2025 | |
| Hologic Sales and Service, LLC | $21.40 | 2024 | Aptima |
| Exact Sciences Corporation | $20.19 | 2025 | The Cologuard Plus Collection Kit |
| Actelion Pharmaceuticals US, INC. | $18.92 | 2024 | Uptravi, Opsumit |
| Abbott Laboratories | $15.73 | 2021 | |
| Novartis Pharmaceuticals Corporation | $14.08 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $11.98 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Catherine Burley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.